Home › Upcoming votes › LISATA THERAPEUTICS, INC.
Read the proxy statement on EDGAR
Ballot read from the proxy statement and checked. As listed in LISATA THERAPEUTICS, INC.’s proxy statement, with the board’s recommendation on each item.
| # | Item | Proposed by | Board recommends | Last year (same kind of item) |
|---|---|---|---|---|
| 1 | ELECTION OF DIRECTORS Director election |
Board | For | — |
| 2 | RATIFICATION OF SELECTION OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM Auditor |
Board | For | 99% support |
| 3 | APPROVAL OF ISSUANCE OF SHARES UPON CONVERSION OF SERIES C PREFERRED STOCK | Board | For | — |
| 4 | APPROVAL OF REVERSE STOCK SPLIT | Board | For | — |
| 5 | APPROVAL OF 2026 EQUITY INCENTIVE PLAN | Board | For | — |
| 6 | APPROVAL OF 2026 ESPP | Board | For | — |
| 7 | THE NON-BINDING, ADVISORY VOTE ON NAMED EXECUTIVE OFFICER COMPENSATION Say on pay |
Board | For | 86% support |
| 8 | ADJOURNMENT PROPOSAL Adjournment |
Board | For | — |
From LISATA THERAPEUTICS, INC.’s Form 8-K, filed June 10, 2025, for the meeting held June 10, 2025 (read it on EDGAR). Support is the share of votes cast that were FOR: abstentions and broker non-votes are left out.
| Item | Support (of votes cast) | Reported outcome |
|---|---|---|
| 2. An amendment to the 2017 Employee Stock Purchase Plan that increases the number of shares available under the plan from 113,333 to 158,33 | 92% | Approved |
| 3. The appointment of Grant Thornton LLP as the Company's independent registered public accounting firm for the fiscal year ending December | 99% | Approved |
| 4. On a non-binding advisory basis, the executive compensation of the Company's named executive officers as described in the Proxy Statement | 86% | Approved |
The meeting facts and ballot come from the SEC proxy filings listed above. Ballots are read from the proxy statement and checked against the filing’s own text; when that check does not pass, the page shows “see the proxy statement” instead of a ballot. Last year’s figures are the company’s official Form 8-K results and the managers’ Form N-PX reports. Nothing on this page predicts how any shareholder will vote, and it is not investment advice. How this works.